| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0077 | 1 |